Vikas Goyal - Net Worth and Insider Trading
Vikas Goyal Net Worth
The estimated net worth of Vikas Goyal is at least $8 Million dollars as of 2024-11-13. Vikas Goyal is the See Remarks of Pandion Therapeutics Inc and owns about 87,764 shares of Pandion Therapeutics Inc (PAND) stock worth over $5 Million. Vikas Goyal is the Director of Spero Therapeutics Inc and owns about 1,854,006 shares of Spero Therapeutics Inc (SPRO) stock worth over $2 Million. Vikas Goyal is also the Director of Morphic Holding Inc and owns about 1,000 shares of Morphic Holding Inc (MORF) stock worth over $56,990. Details can be seen in Vikas Goyal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vikas Goyal has not made any transactions after 2021-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vikas Goyal
Vikas Goyal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vikas Goyal owns 3 companies in total, including Pandion Therapeutics Inc (PAND) , Morphic Holding Inc (MORF) , and Spero Therapeutics Inc (SPRO) .
Click here to see the complete history of Vikas Goyal’s form 4 insider trades.
Insider Ownership Summary of Vikas Goyal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | See Remarks |
| MORF | Morphic Holding Inc | 2021-03-05 | director |
| SPRO | Spero Therapeutics Inc | 2017-11-06 | director |
Vikas Goyal Latest Holdings Summary
Vikas Goyal currently owns a total of 3 stocks. Among these stocks, Vikas Goyal owns 87,764 shares of Pandion Therapeutics Inc (PAND) as of July 21, 2020, with a value of $5 Million and a weighting of 67.87%. Vikas Goyal owns 1,854,006 shares of Spero Therapeutics Inc (SPRO) as of November 6, 2017, with a value of $2 Million and a weighting of 31.4%. Vikas Goyal also owns 1,000 shares of Morphic Holding Inc (MORF) as of March 5, 2021, with a value of $56,990 and a weighting of 0.73%.
Latest Holdings of Vikas Goyal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | 87,764 | 60.05 | 5,270,228 |
| SPRO | Spero Therapeutics Inc | 2017-11-06 | 1,854,006 | 1.32 | 2,438,018 |
| MORF | Morphic Holding Inc | 2021-03-05 | 1,000 | 56.99 | 56,990 |
Holding Weightings of Vikas Goyal
Vikas Goyal Form 4 Trading Tracker
According to the SEC Form 4 filings, Vikas Goyal has made a total of 1 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 1,450 shares on July 21, 2020, which cost Vikas Goyal around $26,100.
According to the SEC Form 4 filings, Vikas Goyal has made a total of 0 transactions in Spero Therapeutics Inc (SPRO) over the past 5 years. The most-recent trade in Spero Therapeutics Inc is the acquisition of 428,571 shares on November 6, 2017, which cost Vikas Goyal around $6 Million.
According to the SEC Form 4 filings, Vikas Goyal has made a total of 1 transactions in Morphic Holding Inc (MORF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Morphic Holding Inc is the acquisition of 1,000 shares on March 5, 2021, which cost Vikas Goyal around $70,000.
Insider Trading History of Vikas Goyal
- 1
Vikas Goyal Trading Performance
GuruFocus tracks the stock performance after each of Vikas Goyal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vikas Goyal is -20.79%. GuruFocus also compares Vikas Goyal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vikas Goyal within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vikas Goyal's insider trading performs compared to the benchmark.
Performance of Vikas Goyal
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.42 | | | | | |
| Relative Return to S&P 500(%) | -7.31 | | | | | |
Vikas Goyal Ownership Network
Ownership Network List of Vikas Goyal
Ownership Network Relation of Vikas Goyal
Vikas Goyal Owned Company Details
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Vikas Goyal is the See Remarks of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Boxer Capital, Llc , and 10 percent owner Polaris Partners VIII, L.P. .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
Vikas Goyal Mailing Address
Above is the net worth, insider trading, and ownership report for Vikas Goyal. You might contact Vikas Goyal via mailing address: C/o Sr One, Ltd., 161 Washington St., Suite 500, Eight Tower Bridge, Conshohocken Pa 19428.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
